Introduction: Hypertension is still a major problem in the field of health problems in general. One therapy to cure hypertension is cupping technique therapy.
Objectives: To find a picture of a brief decrease in blood pressure in patients with hypertension using cupping therapy techniques.
Methods: This study was a descriptive study using purposive sampling totaling 85 populations and 46 samples.
Results: The results showed that the average systolic blood pressure before cupping was 164.78 mmHg decreased by 10.87 mmHg to 153.91 mmHg after cupping and the average diastolic blood pressure before cupping was 99.78 mmHg decreased by 4.13 mmHg to 95.65 mmHg.
Conclusion: The results showed that cupping technique therapy can reduce blood pressure for a moment in hypertension sufferers.
2. Puspitasari, V. et al. Serum vascular endothelial growth factor as a predictor of clinical outcomes in anterior circulation ischemic stroke. Med. J. Indones. 24, 109–114 (2015).
3. Chowdhury, E. K., Ademi, Z., Moss, J. R., Wing, L. M. H. & Reid, C. M. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly australians considering diabetes as comorbidity. Med. (United States) 94, e590 (2015).
4. Mehta, P. & Dhapte, V. Cupping therapy: A prudent remedy for a plethora of medical ailments. J. Tradit. Complement. Med. 5, 127–134 (2015).
5. Hypertension, I. of M. (US) C. on P. H. P. to R. and C. No Title. in A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension (National Academies Press (US), 2010).
6. Gu, J. wei et al. Long-term high salt diet causes hypertension and alters renal cytokine gene expression profiles in Sprague-Dawley rats. Beijing Da Xue Xue Bao. 41, 505–515 (2009).
7. Mutua, E. M. et al. Level of blood pressure control among hypertensive patients on follow-up in a Regional Referral Hospital in Central Kenya. Pan Afr. Med. J. 18, 278 (2014).
8. Al-Bedah, A. M. N. et al. The medical perspective of cupping therapy: Effects and mechanisms of action. J. Tradit. Complement. Med. 9, 90–97 (2019).
9. AF, J. The lung and the metabolism of vasoactive substances. Schweiz Med Wochenschr. 105, 1656–8 (1975).
10. Burford, N. G., Webster, N. A. & Cruz-Topete, D. Hypothalamic-pituitary-adrenal axis modulation of glucocorticoids in the cardiovascular system. Int. J. Mol. Sci. 18, 1–16 (2017).